234 related articles for article (PubMed ID: 28404921)
21. Prognostic value of microRNA-145 in patients with various cancers: a meta-analysis.
Dai SL; Zhou J; Pan C; Huang G; Shi ZL; Yang SY; Yang KX
Cancer Biomark; 2015; 15(4):507-13. PubMed ID: 25792469
[TBL] [Abstract][Full Text] [Related]
22. Potential Role of MicroRNA-375 as Biomarker in Human Cancers Detection: A Meta-Analysis.
Yan J; She Q; Shen X; Zhang Y; Liu B; Zhang G
Biomed Res Int; 2017; 2017():1875843. PubMed ID: 29259977
[TBL] [Abstract][Full Text] [Related]
23. Clinical utility of microRNA-378 as early diagnostic biomarker of human cancers: a meta-analysis of diagnostic test.
Li ZZ; Shen LF; Li YY; Chen P; Chen LZ
Oncotarget; 2016 Sep; 7(36):58569-58578. PubMed ID: 27448977
[TBL] [Abstract][Full Text] [Related]
24. The Diagnostic Power of Circulating miR-1246 in Screening Cancer: An Updated Meta-analysis.
Huynh KQ; Le AT; Phan TT; Ho TT; Pho SP; Nguyen HT; Le BT; Nguyen TT; Nguyen ST
Oxid Med Cell Longev; 2023; 2023():8379231. PubMed ID: 37122536
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic and prognostic value of microRNA-486 in patients with lung cancer: A systematic review and meta-analysis.
Shen X; Li L; Zhang L; Liu W; Wu Y; Ma R
Int J Biol Markers; 2022 Dec; 37(4):377-385. PubMed ID: 35902998
[TBL] [Abstract][Full Text] [Related]
26. Integrated Analysis Reveals That Long Non-Coding RNA TUBA4B Can Be Used as a Prognostic Biomarker in Various Cancers.
Zhang T; Wu DM; Deng SH; Han R; Liu T; Li J; Xu Y
Cell Physiol Biochem; 2018; 49(2):530-544. PubMed ID: 30157490
[TBL] [Abstract][Full Text] [Related]
27. Diagnostic value of circulating miR-21 for colorectal cancer: a meta-analysis.
Shan L; Ji Q; Cheng G; Xia J; Liu D; Wu C; Zhu B; Ding Y
Cancer Biomark; 2015; 15(1):47-56. PubMed ID: 25524942
[TBL] [Abstract][Full Text] [Related]
28. Potential Role of MicroRNA-210 as Biomarker in Human Cancers Detection: A Meta-Analysis.
Lu J; Xie F; Geng L; Shen W; Sui C; Yang J
Biomed Res Int; 2015; 2015():303987. PubMed ID: 26446394
[TBL] [Abstract][Full Text] [Related]
29. Diagnostic and prognostic value of microRNA-21 in colorectal cancer: an original study and individual participant data meta-analysis.
Zhang H; Li P; Ju H; Pesta M; Kulda V; Jin W; Cai M; Liu C; Wu H; Xu J; Ye Y; Zhang G; Xu E; Cai J; Lai M; Xia D; Yang J; Wu Y
Cancer Epidemiol Biomarkers Prev; 2014 Dec; 23(12):2783-92. PubMed ID: 25178983
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic Value of MicroRNA-18a for Gastric Cancer: a Meta-Analysis.
Liang Q; Zhang G; Wang J; Sheng S
Clin Lab; 2018 Jan; 64(1):177-184. PubMed ID: 29479894
[TBL] [Abstract][Full Text] [Related]
31. Potential role of microRNA-126 in the diagnosis of cancers: A systematic review and meta-analysis.
Yan J; Ma S; Zhang Y; Yin C; Zhou X; Zhang G
Medicine (Baltimore); 2016 Aug; 95(35):e4644. PubMed ID: 27583885
[TBL] [Abstract][Full Text] [Related]
32. Investigation of the value of miR-21 in the diagnosis of early stage HCC and its prognosis: a meta-analysis.
Yan SR; Liu ZJ; Yu S; Bao YX
Genet Mol Res; 2015 Sep; 14(3):11573-86. PubMed ID: 26436398
[TBL] [Abstract][Full Text] [Related]
33. AlncRNA HULC as an effective biomarker for surveillance of the outcome of cancer: A meta-analysis.
Chen X; Lin J; Liu Y; Peng J; Cao Y; Su Z; Wang T; Cheng J; Hu D
PLoS One; 2017; 12(2):e0171210. PubMed ID: 28146578
[TBL] [Abstract][Full Text] [Related]
34. A Circulating MicroRNA-375 for the Detection of Liver Cancer: A Meta-Analysis.
Kong X; He Z; Ji Z; Fu T; Yuan X; Zhou H; Shao Z; Zhang W
Genet Test Mol Biomarkers; 2022 Dec; 26(12):564-572. PubMed ID: 36577123
[No Abstract] [Full Text] [Related]
35. Detection Performance of Circulating MicroRNA-210 for Renal Cell Carcinoma: a Meta-Analysis.
Chen Y; Wang X; Zhu X; Shao S
Clin Lab; 2018 Apr; 64(4):569-576. PubMed ID: 29739083
[TBL] [Abstract][Full Text] [Related]
36. Circulating miR-21 as a potential biomarker in human digestive system carcinoma: a systematic review and diagnostic meta-analysis.
Aalami AH; Abdeahad H; Mesgari M
Biomarkers; 2021 Mar; 26(2):103-113. PubMed ID: 33434077
[No Abstract] [Full Text] [Related]
37. MiR-486 as an effective biomarker in cancer diagnosis and prognosis: a systematic review and meta-analysis.
Jiang M; Li X; Quan X; Yang X; Zheng C; Hao X; Qu R; Zhou B
Oncotarget; 2018 Mar; 9(17):13948-13958. PubMed ID: 29568407
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic value of circulating miR-21: An update meta-analysis in various cancers and validation in endometrial cancer.
Gao Y; Dai M; Liu H; He W; Lin S; Yuan T; Chen H; Dai S
Oncotarget; 2016 Oct; 7(42):68894-68908. PubMed ID: 27655698
[TBL] [Abstract][Full Text] [Related]
39. Gastric Cancer and Circulating microRNAs: An Updated Systematic Review and Diagnostic Meta-Analysis.
Aalami AH; Aalami F; Sahebkar A
Curr Med Chem; 2023; 30(33):3798-3814. PubMed ID: 36411580
[TBL] [Abstract][Full Text] [Related]
40. Diagnostic and prognostic value of microRNA-628 for cancers.
Li JH; Sun SS; Fu CJ; Zhang AQ; Wang C; Xu R; Xie SY; Wang PY
J Cancer; 2018; 9(9):1623-1634. PubMed ID: 29760801
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
